Jacobs, S. A., Robidoux, A., Abraham, J., Pérez-Garcia, J. M., La Verde, N., Orcutt, J. M., . . . Pogue-Geile, K. L. (2019). NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2(+) breast cancer. Breast Cancer Res.
シカゴスタイル引用形Jacobs, Samuel A., et al. "NSABP FB-7: A Phase II Randomized Neoadjuvant Trial With Paclitaxel + Trastuzumab And/or Neratinib Followed By Chemotherapy and Postoperative Trastuzumab in HER2(+) Breast Cancer." Breast Cancer Res 2019.
MLA引用形式Jacobs, Samuel A., et al. "NSABP FB-7: A Phase II Randomized Neoadjuvant Trial With Paclitaxel + Trastuzumab And/or Neratinib Followed By Chemotherapy and Postoperative Trastuzumab in HER2(+) Breast Cancer." Breast Cancer Res 2019.